Asthmatic, Healthy, Immunosuppressed, Neuromuscular Diseases
Conditions
Keywords
Influenza A H1N1, Children, Epidemiology, Treatment, Oseltamivir, Genetics
Brief summary
This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.
Interventions
None listed
Sponsors
University Hospital, Geneva
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 16 Years
Healthy volunteers
No
Inclusion criteria
* suspicion of H1N1 infection
Exclusion criteria
* Not available for a 30 days follow-up
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ABCB1 polymorphisms | 6 months | ABCB1 gene polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia |
Countries
Switzerland
Outcome results
None listed